Today on Drug Development Technology
-
Simbrinza (brinzolamide/brimonidine tartrate) for the Reduction of Elevated Intraocular Pressure
http://www.drugdevelopment-technology.com/projects/8399/main.jpgSimbrinza (brinzolamide/brimonidine tartrate) is a carbonic anhydrase inhibitor developed by Alcon, a division of...
-
Oxytrol (oxybutynin) for the Treatment of Overactive Bladder (OAB) in Women
http://www.drugdevelopment-technology.com/projects/8363/main.jpgOxytrol (oxybutynin) is a transdermal patch indicated for the treatment of overactive bladder in women who have symptoms of urge urinary incontinence, urgency and frequency....
-
Zytiga (abiraterone acetate) - Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)
http://www.drugdevelopment-technology.com/projects/drug_abiateronecance/images/main.jpgDeveloped by Coughar Biotechnology, abiraterone acetate (CB7630) was discovered by the UK Institute for Cancer Research....
-
Korlym (Mifepristone) for Treatment of Endogenous Cushing’s Syndrome
http://www.drugdevelopment-technology.com/projects/8350/main.jpgKorlym (mifepristone) is a glucocorticoid receptor blocker indicated for the control of high blood sugar levels in adult patients suffering from endogenous Cushing's syndrome....
Latest Suppliers
Temperature Maintenance of Biopharmaceuticals USA 2013
After last year's highly successful launch of the Temperature Maintenance of Biopharmaceuticals, the conference will return to Boston, MA, on 5 - 6 June. Focusing on the most relevant...
After last year's highly successful launch of the Temperature Maintenance of Biopharmaceuticals, the conference will return to Boston, MA, on 5 - 6 June. Focusing on the most relevant...
Latest White Papers
Use of the Fios Genomics Analysis Approach for Determining Immunity Pathways
This study determined which immunological pathways are responsible for clearance of parasitic infections in people affected by river...
This study determined which immunological pathways are responsible for clearance of parasitic infections in people affected by river...
Latest News
Trillium completes dosing in Phase I cystitis/bladder pain syndrome study of TTI-1612
Trillium Therapeutics, a wholly-owned subsidiary of Stem Cell Therapeutics has completed dosing in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) in the Phase I study of...
Trillium Therapeutics, a wholly-owned subsidiary of Stem Cell Therapeutics has completed dosing in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) in the Phase I study of...
Latest Projects
Simbrinza (brinzolamide/brimonidine tartrate) for the Reduction of Elevated Intraocular Pressure
Simbrinza (brinzolamide/brimonidine tartrate) is a carbonic anhydrase inhibitor developed by Alcon, a division of...
Simbrinza (brinzolamide/brimonidine tartrate) is a carbonic anhydrase inhibitor developed by Alcon, a division of...
Latest Press Releases
Proven Autoclave Design a Long Runner
Top-loading laboratory autoclaves are the longest serving stalwarts of the Priorclave steam steriliser range, a 100l model being the first produced and to leave the company's factory in 1988...
Top-loading laboratory autoclaves are the longest serving stalwarts of the Priorclave steam steriliser range, a 100l model being the first produced and to leave the company's factory in 1988...
Latest Features
Straight to the source – targeted pain relief
Diamyd Medical, a Swedish biopharmaceutical company, has taken huge steps towards revolutionising the treatment of intractable pain. Through their Nerve Targeting Drug Delivery System (NTDDS)...
Diamyd Medical, a Swedish biopharmaceutical company, has taken huge steps towards revolutionising the treatment of intractable pain. Through their Nerve Targeting Drug Delivery System (NTDDS)...
Latest Videos
Tissue Solutions Biomarkers Partnership
An introduction to Tissue Solutions' services for drug development companies.
An introduction to Tissue Solutions' services for drug development companies.
Twitter
Facebook